What is Athelas?
Athelas is a pioneering health-tech organization dedicated to simplifying life-changing healthcare through advanced remote patient monitoring (RPM) solutions. The company's platform enables healthcare providers to track critical patient vitals—including blood pressure, weight, and blood glucose—in real-time, facilitating proactive care management. By bridging the gap between clinical oversight and home-based monitoring, Athelas significantly enhances patient engagement while simultaneously reducing the frequency of hospitalizations. This market-leading approach positions the company at the intersection of enterprise SaaS and healthcare infrastructure, addressing the urgent need for scalable, data-driven medical interventions in an increasingly decentralized care environment.
How much funding has Athelas raised?
Athelas has raised a total of $135.5M across 2 funding rounds:
Other Financing Round
$3.5M
Unspecified
$132M
Other Financing Round (2017): $3.5M with participation from Liquid2 Ventures, Steamboat Ventures, Fifty Years, and Initialized Capital
Unspecified (2022): $132M led by Human Capital, Tribe Capital Growth Corp I, Initialized Capital, Sequoia Capital, General Catalyst, GREENOAKS, and Y Combinator
Key Investors in Athelas
Initialized Capital
Initialized Capital is a venture capital firm dedicated to supporting seed stage founders across various sectors including enterprise SaaS, health, and artificial intelligence, providing the necessary tools and guidance for long-term success.
General Catalyst
General Catalyst operates as a venture capital firm focused on identifying and supporting transformational business opportunities, leveraging deep sector expertise to accelerate growth in healthcare and enterprise software.
Sequoia Capital
Sequoia Capital is a globally recognized venture firm that partners with entrepreneurs to create market leaders, providing extensive operational support and a long-term investment perspective.
What's next for Athelas?
Looking ahead, the recent capital infusion is expected to accelerate the deployment of Athelas's technology across broader healthcare networks, further cementing its role as an essential partner for modern medical institutions. The strategic focus will likely shift toward deepening integration with existing electronic health record (EHR) systems and expanding the diagnostic capabilities of its remote monitoring suite. As the company scales, it remains well-positioned to capitalize on the growing demand for virtual care, leveraging its strong investor base to navigate the complexities of the global healthcare market and drive long-term, sustainable value for both providers and patients.
See full Athelas company page
